Ecotality Inc. (ECTY) shares plunged to the new 52W low on Friday’s trading session most likely based on investors fear after Romney’s campaign ad. Romney draws parallels between the government loans went to Solyndra (note: Solyndra got $535 million loan and filed for Chapter 11 bankruptcy soon thereafter) and the U.S. Department of Energy (DOE) […]
MediciNova, Inc. (MNOV) Stock Is Getting Back on Track

MediciNova, Inc. (MNOV) reported yesterday that preliminary results from a hospital emergency department (ED)-based Phase 2b clinical trial evaluating its MN-221 in patients with acute exacerbations of asthma did not statistically meet the primary endpoint, improvement in FEV1 (Forced Expiratory Volume in One Second) compared to placebo. MediciNova’s stockholders clearly reacted on these disappointed results: MNOV […]
MEMSIC, Inc. (Nasdaq: MEMS): Market Overreaction

MEMSIC, Inc. (Nasdaq: MEMS) announced financial results for the first quarter ended March 31, 2012: Revenues rose to $20.0 million from $13.0 million in the 2011 quarter. Total shipments of our sensor products grew to 32.1 million units from 12.6 million units in the prior-year period. Gross margin was 37.1% compared to 38.1% in the […]
EDAP TMS SA (Nasdaq:EDAP): Notes for Your Throughts

EDAP TMS SA (EDAP) Some remarks for you: – EDAP is the global leader in therapeutic ultrasound with its Ablatherm-HIFU (High-intensity Focused Ultrasound) device – Read the article “Ultrasound May Permit Prostate Lumpectomies, Study Says“; excerpt is below for your convenience: [note color=”#CDCAE0″]The technology enables doctors to preserve the prostate by aiming only at the […]
Keryx Biopharmaceuticals (Nasdaq:KERX): Bounce Candidate

Shares of Keryx Biopharmaceuticals (Nasdaq:KERX) got slammed today after the company announced that their cancer drug trial, KRX-0401 (in-licensed by Keryx from AeternaZentaris Inc. (AEZS) in the United States, Canada and Mexico), failed. Ron Bentsur, Chief Executive Officer of Keryx, stated: We are all extremely disappointed with the results of the study. We thank the […]
Autobytel Inc. (ABTL): Growth in Revenue and Profitability for 2012

Autobytel Inc. (Nasdaq: ABTL) announced today after-hours that it expects to achieve meaningful growth in revenue and profitability for 2012. Jeffery Coats , President and Chief Executive Officer of Autobytel, said at the 24th Annual Roth conference: We anticipate strong growth this year, driven, in part, by increasing recognition from our automotive manufacturer and dealer customers […]
Zalicus Inc. (NASDAQ: ZLCS): Completion of a Phase 1 Clinical Trial

Zalicus Inc. (NASDAQ: ZLCS) today announced the successful completion of a Phase 1 clinical trial evaluating the pharmacokinetics and safety of a new formulation of Z160, a novel oral N-type calcium channel blocker. In the company’s study, Z160 demonstrated substantial bioavailability and solubility improvements using a novel, proprietary formulation technology. Based on the data from […]
Tibet Pharmaceuticals, Inc. (TBET): Going Private

Tibet Pharmaceuticals, Inc. (NASDAQ: TBET) announced on February 27th its intent to accept a “going private” and cease its public company status. Mr. Hong Yu, CEO and Chairman of Tibet Pharmaceuticals, made an offer to purchase TBET stocks not owned by him for $3.00 per share in cash. Mr. Hong Yu commented: “In recent days, […]
Satcon Technology Corporation (SATC): Strategic Sales and Manufacturing Partnership

Satcon Technology Corporation (SATC) today announced a partnership with Great Wall Computer Company Limited (GWPC), a majority-owned subsidiary of China Electronics Corporation (CEC). The partnership will position Satcon to capitalize on the estimated 14GW of utility scale projects under development, fueled by the country’s Feed-In Tariff program. The partnership includes a five-year contract manufacturing agreement […]
NEI: Going Up for the Week of January 9th, 2012
NEI (NASDAQ: NEI) today announced the financial outlook for the fiscal quarter ended December 31, 2011. Highlights: Net revenues in the range of $68 million to $70 million, greater than the original guidance of $58 million to $63 million provided on November 10, 2011. Net income on a GAAP basis in the range of $1.3 […]